Bright Minds Biosciences Logo

Bright Minds Biosciences

🇺🇸
DRUG
CA10919W4056

Bright Minds Biosciences is a US-based biotech company specializing in the development of innovative therapeutics to treat neurological and psychiatric disorders. The company focuses on novel drug candidates that precisely target serotonin receptors to advance treatments for mental health conditions.

Next Quarterly Earnings

Tuesday, May 18, 2027
Expected

Stock Price

Frequently asked questions

When did Bright Minds Biosciences last report quarterly earnings?

Bright Minds Biosciences last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 USD.

How often has Bright Minds Biosciences beaten expectations?

Bright Minds Biosciences has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Bright Minds Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:-$1.28
Actual:-$0.17
Difference:+$1.11
Price reaction (1 day):+4.0 %
Q1 2026
Beat
Estimate:-$0.88
Actual:-$0.79
Difference:+$0.08
Price reaction (1 day):+11.1 %
Price reaction (7 days):+15.8 %
Q3 2025
Beat
Estimate:-$1.19
Actual:-$0.97
Difference:+$0.22
Q2 2025
Beat
Estimate:-$1.00
Actual:-$0.58
Difference:+$0.42
Q1 2025
Beat
Estimate:-$0.88
Actual:-$0.74
Difference:+$0.14

Earnings statistics

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+19.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Bright Minds Biosciences
Ticker Symbol
DRUG
ISIN
CA10919W4056
Country
🇺🇸
USA
Sector